Page last updated: 2024-09-05

campesterol and sitagliptin phosphate

campesterol has been researched along with sitagliptin phosphate in 1 studies

Compound Research Comparison

Studies (campesterol)	Trials (campesterol)	Recent Studies (post-2010) (campesterol)	Studies (sitagliptin phosphate)	Trials (sitagliptin phosphate)	Recent Studies (post-2010) (sitagliptin phosphate)
410	75	166	1,715	471	1,390

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arasaki, O; Chihara, A; Morimoto, T; Node, K; Nomiyama, T; Sakuma, M; Shimabukuro, M; Tanaka, A; Ueda, S	1

Trials

1 trial(s) available for campesterol and sitagliptin phosphate

Article	Year
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial. Cardiovascular diabetology, 2019, 11-16, Volume: 18, Issue:1 Topics: Aged; Biomarkers; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Phytosterols; Pyrimidines; Sitagliptin Phosphate; Sitosterols; Time Factors; Treatment Outcome	2019

Article

Year

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial.

Cardiovascular diabetology, 2019, 11-16, Volume: 18, Issue:1

Topics: Aged; Biomarkers; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Phytosterols; Pyrimidines; Sitagliptin Phosphate; Sitosterols; Time Factors; Treatment Outcome

2019